Mizoribine, an imidazole nucleoside, inhibited the chaperoning activity of the Hsp60–Hsp10 complex by interacting with Hsp60 to implement the immunosuppressive effect in breast cancer progression [51]. This evidence concerns the gene HSPD1 and breast carcinoma.